Unknown

Dataset Information

0

Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.


ABSTRACT: The important roles of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) are widely accepted in various biological processes as well as metabolic diseases. Despite the worldwide quest for pharmaceutical manipulation of PPARgamma activity through the ligand-binding domain, very little information about the activation mechanism of the N-terminal activation function-1 (AF-1) domain. Here, we demonstrate the molecular and structural basis of the phosphorylation-dependent regulation of PPARgamma activity by a peptidyl-prolyl isomerase, Pin1. Pin1 interacts with the phosphorylated AF-1 domain, thereby inhibiting the polyubiquitination of PPARgamma. The interaction and inhibition are dependent upon the WW domain of Pin1 but are independent of peptidyl-prolyl cis/trans-isomerase activity. Gene knockdown experiments revealed that Pin1 inhibits the PPARgamma-dependent gene expression in THP-1 macrophage-like cells. Thus, our results suggest that Pin1 regulates macrophage function through the direct binding to the phosphorylated AF-1 domain of PPARgamma.

SUBMITTER: Fujimoto Y 

PROVIDER: S-EPMC2823398 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.

Fujimoto Yoshito Y   Shiraki Takuma T   Horiuchi Yuji Y   Waku Tsuyoshi T   Shigenaga Akira A   Otaka Akira A   Ikura Tsuyoshi T   Igarashi Kazuhiko K   Aimoto Saburo S   Tate Shin-ichi S   Morikawa Kosuke K  

The Journal of biological chemistry 20091207 5


The important roles of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) are widely accepted in various biological processes as well as metabolic diseases. Despite the worldwide quest for pharmaceutical manipulation of PPARgamma activity through the ligand-binding domain, very little information about the activation mechanism of the N-terminal activation function-1 (AF-1) domain. Here, we demonstrate the molecular and structural basis of the phosphorylation-dependen  ...[more]

Similar Datasets

| S-EPMC7076253 | biostudies-literature
| S-EPMC7243138 | biostudies-literature
| S-EPMC6494719 | biostudies-literature
| S-EPMC7113879 | biostudies-literature
| S-EPMC26842 | biostudies-literature
| S-EPMC7286916 | biostudies-literature
| S-EPMC2792957 | biostudies-literature
| S-EPMC3896615 | biostudies-literature
| S-EPMC2527300 | biostudies-literature
| S-EPMC3579456 | biostudies-literature